Cancer Advances
Subscribe:
Featured Episode
Unlocking the Impact of ESR1 Mutations and PI3K Pathway on Elacestrant in Advanced Breast Cancer
Ali Azka, MD, medical oncologist specializing in breast cancer joins the Cancer Advances podcast to talk about her new research on ESR1 mutations and the PI3-kinase pathway's impact on the effectiveness of elacestrant in treating advanced hormone receptor-positive, HER2-negative breast cancer. This study, presented at the 2024 San Antonio Breast Cancer Symposium (SABCS), highlights the role of real-world data, optimal treatment sequencing, and the evolving landscape of targeted therapies. Tune in as Dr. Azka explores these advancements and their potential to improve patient outcomes.
Play NowAll Cancer Advances Episodes
December 12, 2024
Integrated Program for Young People with Cancer
Chair of the Department of Colorectal Surgery, Director of the Weiss Center for Hereditary GI Neoplasia and Center for Young Onset Colorectal Cancer, David Liska, MD, joins the Cancer Advances Podcast to discuss Cleveland Clinic's integrated program for young people with cancer. Listen as Dr. Liska explains the rise in early-onset cancers, potential factors, and the unique challenges young patients face. Learn how this comprehensive program leverages multidisciplinary care, advanced research, and innovative technology to improve outcomes and survivorship for young cancer patients.
Play NowDecember 5, 2024
Evolving Care for Relapsed Multiple Myeloma
Beth Faiman, PhD, CNP, a Nurse Practitioner and Clinical Researcher at Cleveland Clinic specializing in multiple myeloma, joins the Cancer Advances podcast to discuss updates in managing relapsed and refractory multiple myeloma. Listen as Dr. Faiman talks about advancements in treatment, including proteasome inhibitors, monoclonal antibodies, and bispecific antibodies, which improve both survival rates and the quality of life for patients. She also highlights key research presented at the International Myeloma Society meeting, focusing on CAR T-cell therapy, transplant eligibility criteria, and personalized treatment planning.
Play NowNovember 21, 2024
Leveraging Oncology Treatments for Vascular Anomalies
Michael Kelly, MD, PhD, a pediatric hematologist and oncologist at Cleveland Clinic Children's, joins the Cancer Advances podcast to discuss innovative care for vascular anomalies. In this episode, Dr. Kelly explains how they are exploring advanced treatments, including clinical trials using cancer medications to address these non-cancerous conditions, the impact of somatic mutations, and the evolving role of genetic research. Discover the latest advances and how these efforts aim to improve both the quality of life and outcomes for patients facing these rare and challenging conditions.
Play NowNovember 14, 2024
Unveiling the Cellular and Immunotherapy Service (CITS)
Inpatient Director of the Cellular and Immunotherapy Service, John Molina, MD, EdM, joins the Cancer Advances podcast to talk about the launching of the Cellular and Immunotherapy Service to manage the growing number of patients receiving cellular therapies like CAR-T and bispecific antibodies. Listen as Dr. Molina share insights on the protocols that help identify and mitigate toxicities early, reducing ICU stays and enhancing patient outcomes with the long-term goal of transitioning more patients to outpatient management where possible.
Play Now
